Jardiance vs. Ozempic

See how Jardiance and Ozempic compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Jardiance is a once-daily pill while Ozempic is a once-weekly injection, so the two fit very different daily routines.

  • Jardiance lowers blood sugar by removing glucose through urine, while Ozempic mimics a gut hormone that slows digestion and reduces appetite.

  • Both drugs cut cardiovascular risk in type 2 diabetes with heart disease and slow chronic kidney disease, but only Ozempic is associated with significant weight loss.

Jardiance vs. Ozempic Drug Summary

Jardiance

Jardiance (empagliflozin) is an SGLT2 inhibitor used to control blood sugar in type 2 diabetes and to lower cardiovascular and kidney risks. It comes as a once-daily oral tablet that can be taken with or without food.

Ozempic

Ozempic (semaglutide) is a GLP-1 receptor agonist used to control blood sugar in type 2 diabetes and reduce cardiovascular risk in people with heart disease. It is injected under the skin once a week, with the dose increased gradually over several weeks.

Jardiance vs. Ozempic Side Effects

Jardiance

Most common
hypoglycemia (up to 41.3%)
increased urination (up to 10%)
dyslipidemia (up to 10%)
urinary tract infection (up to 9.3%)

Ozempic

Most common
nausea (up to 20.3%)
vomiting (up to 9.2%)
diarrhea (up to 8.8%)
abdominal pain (up to 7.3%)

Jardiance vs. Ozempic Dosage

Jardiance

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 10 mg once daily At the start
Maximum dose 25 mg once daily If needed
Dose changes 1 increase As tolerated

Ozempic

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 0.25 mg once weekly Weeks 1-4
Maximum dose 0.5 mg once weekly Week 5 onward
Dose changes 1 increase Every 4 weeks

Jardiance vs. Ozempic Indications

Jardiance

Jardiance is FDA-approved for blood sugar control in adults and children 10 and older with type 2 diabetes. It is also approved to reduce cardiovascular death risk in adults with heart disease, to reduce cardiovascular death and hospitalization in heart failure, and to slow chronic kidney disease progression.

  • Blood sugar control in type 2 diabetes (adults and children 10+)

  • Reduce cardiovascular death risk with heart disease

  • Reduce cardiovascular death and hospitalization in heart failure

  • Slow chronic kidney disease progression

Ozempic

Ozempic is FDA-approved for blood sugar control in adults with type 2 diabetes, used alongside diet and exercise. It also reduces the risk of major cardiovascular events in people with type 2 diabetes and known heart disease, and slows kidney damage progression in those with chronic kidney disease.

  • Blood sugar control in type 2 diabetes (adults)

  • Reduce major cardiovascular events with heart disease

  • Slow kidney damage progression with chronic kidney disease

  • Off-label: weight loss in people without diabetes (not FDA-approved for this use)

Jardiance vs. Ozempic Pros and Cons

Jardiance

Jardiance is a once-daily pill, appealing to those who prefer to avoid injections. It has been studied for years in heart failure and chronic kidney disease, giving it a broader set of approved uses beyond blood sugar control. Its main risks are genital infections and, rarely, diabetic ketoacidosis even without high blood sugar.

Pros

  • Oral tablet, no injections needed

  • Approved for heart failure regardless of ejection fraction

  • Approved for pediatric patients 10 and older

Cons

  • Risk of genital yeast infections and UTIs

  • Small risk of diabetic ketoacidosis even without high blood sugar

  • Not linked to significant weight loss like GLP-1 drugs

  • Risk of dehydration and low blood pressure in older adults

Ozempic

Ozempic requires only one injection per week, but nausea and other digestive side effects are common, especially during dose increases. It carries a boxed warning for thyroid C-cell tumors seen in animal studies and is not recommended for those with a personal or family history of certain thyroid cancers. Many people also see meaningful weight loss on the medication, though it is not FDA-approved specifically for that use.

Pros

  • Only needs to be taken once a week

  • Often leads to meaningful weight loss

  • Approved to slow kidney damage progression with chronic kidney disease

Cons

  • Boxed warning for thyroid C-cell tumor risk in animal studies

  • Common nausea, vomiting, and digestive side effects

  • Not approved for chronic weight management (that indication belongs to Wegovy)

  • Roughly $935 to $1,043 per month without insurance

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.